Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of Selinexor Plus Bortezomib, Lenalidomide and Dexamethasone (XVRd) in High Risk Newly Diagnosed Multiple Myeloma: A Multi-Center, Single-Arm, Phase Ib/II Trial

Xiaoqin Chen, Yun Wang, Weida Wang, Hua Wang, Bingyi Wu, Yang Liang, Zhongjun Xia

Blood (2024) 144 (Supplement 1): 7025.

https://doi.org/10.1182/blood-2024-204564

Published: 2024

Journal Articles

Efficiency and Safety of Pegylated Filgrastim Combined with Plerixafor in Multiple Myeloma Autologous Hematopoietic Stem Cells Mobilization

Chenfei Liu, Yuanbin Song, Yang Liang, Lu Lu, Weida Wang, Bingyi Wu

Blood (2024) 144 (Supplement 1): 7118.

https://doi.org/10.1182/blood-2024-207526

Published: 2024

Journal Articles

Safety and Efficacy of Luspatercept in Low-Risk Myelodysplastic Neoplasms with Anaemia

Yang Liang, Yuanbin Song, Chenfei Liu, Lu Lu, Bingyi Wu, Weida Wang, Shuzhao Chen, Lezong Chen

Blood (2024) 144 (Supplement 1): 6713.

https://doi.org/10.1182/blood-2024-207749

Published: 2024

Journal Articles

Mitoxantrone Hydrochloride Liposome Combined with Cytarabine As Induction Therapy for Patients with Newly Diagnosed Secondary Acute Myeloid Leukemia

Yun Wang, Weida Wang, Jingbo Xu, Ji Ma, Hua Wang, Bingyi Wu, Yuanbin Song, Weiran Lv, Lezong Chen, Jun Ma, Tiejun Gong, Yang Liang

Blood (2024) 144 (Supplement 1): 6074.

https://doi.org/10.1182/blood-2024-209055

Published: 2024

Journal Articles

ABC Regimen (Azacitidine, Venetoclax and Chidamide) Is Comparable to the “3+7” Regimen in Newly Diagnosed AML: A Real-World Experience from South China

Blood (2023) 142 (Supplement 1): 1522.

https://doi.org/10.1182/blood-2023-188196

Published: 2023

Journal Articles

A Preliminary Analysis of Chidamide Combined with R-GemOx (rituximab, gemcitabine and oxaliplatin) As Salvage Treatment for Transplant-Ineligible Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Study

Qingqing Cai, Yi Xia, Hui Zhou, Wenyu Li, Zhiming Li, Xu Ye, Yudan Wu, Huo Tan, Runhui Zheng, Bingyi Wu, Hui Yang, Yuhong Lu, Yang Liang, Ning Su, Qihua Zou, Panpan Liu

Blood (2022) 140 (Supplement 1): 9450–9451.

https://doi.org/10.1182/blood-2022-166080

Published: 2022

Journal Articles

Higher-Dose Donor Derived Ex Vivo Expanded Natural Killer Cell Infusion Prior to Haploidentical Stem Cell Transplantation on Acute Myeloid Leukemia: Efficacy and Safety

Weida Wang, Yang Liang, Yuanbin Song, Hanying Huang, Bingyi Wu

Blood (2022) 140 (Supplement 1): 12713.

https://doi.org/10.1182/blood-2022-169773

Published: 2022

Journal Articles

Chidamide Plus R-GemOx(rituximab, gemcitabine and oxaliplatin) Regimen As Salvage Treatment for Transplant-Ineligible Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Preliminary Analysis of a Multicenter, Single Arm, Phase II Study

Qingqing Cai, PhD, Hui Zhou, MDPhD, Zhiming Li, MD PhD, Wenyu Li, PhD, Yudan Wu, MDPhD, Bingyi Wu, MDPhD, Hui Yang, MDPhD, Stephen Yang Liang, MDPhD, Ning Su, MM, Panpan Liu, MD PhD, Xuanye Zhang, MDPhD, Yi Xia, MD PhD, Shuyun Ma, MM

Blood (2020) 136 (Supplement 1): 52–53.

https://doi.org/10.1182/blood-2020-136993

Published: 2020

Journal Articles

Real-World Effectiveness and Safety of Eltrombopag in Patients with Aplastic Anemia: A Chinese Nationwide Survey

Wenrui Yang, MD, Bing Han, MD PhD, Hong Chang, MD, Bingyi Wu, MD, Fankai Meng, Dexiang Ji, MD, Yingmei Li, MD, Zhengjin Zheng, MD, Yan Fei, Jianping Shen, MD, Ping Hu, MD, Jianxiang Wang, MD, Fengkui Zhang, MD

Blood (2019) 134 (Supplement_1): 5020.

https://doi.org/10.1182/blood-2019-126441

Published: 2019

Journal Articles

Eltrombopag Combined with G-CSF and Cyclosporine Could Effect for Severe Acquired Aplastic Anemia

Bingyi Wu, MD, Jiahui Cai, MA, Li Yingshi, MA, Dong Ruihong

Blood (2018) 132 (Supplement 1): 5110.

https://doi.org/10.1182/blood-2018-99-115779

Published: 2018

Journal Articles

Superior Salvage Treatment with Regimen Containing Sorafenib for Relapse of Acute Myeloid Leukemia with FLT3-ITD after Allo-HSCT

Li Xuan, Yu Wang, Jia Chen, Erlie Jiang, Li Gao, Bingyi Wu, MD, Lan Deng, MD PhD, Xinquan Liang, Fen Huang, Zhiping Fan, Xiaowen Tang, Jing Sun, Xi Zhang, Ming-Zhe Han, De-Pei Wu, Xiao Jun Huang, Qifa Liu, MD

Blood (2018) 132 (Supplement 1): 2129.

https://doi.org/10.1182/blood-2018-99-114103

Published: 2018

Journal Articles

The Effect of Sorafenib Therapy on the Outcome of Acute Myeloid Leukemia with FLT3-ITD Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Li Xuan, Yu Wang, Fen Huang, Bingyi Wu, MD, Zhiping Fan, Na Xu, PhD, Jieyu Ye, Jing Sun, MD, Xiaojun Huang, Qifa Liu

Blood (2017) 130 (Supplement 1): 2045.

https://doi.org/10.1182/blood.V130.Suppl_1.2045.2045

Published: 2017

Journal Articles

More Intensity Immuno-Suppression In Conditioning Regimen may Favor Donor Stem Cell Sustained Engraftment In Allogeneic Stem Cell Transplantation For Acquired Severe Aplastic Anemia Patients

Sun Can, Lin Xia, Huang Yuxian, Chen Tuzhen, Bingyi Wu, MD

Blood (2013) 122 (21): 5452.

https://doi.org/10.1182/blood.V122.21.5452.5452

Published: 2013

Journal Articles

Long Term Survival in Refractory Leukemia Patient Treated with Related HLA Haploidentical Stem Cell Transplantation

Bingyi Wu, MD, Guo Kunyuan, Jing Wu

Blood (2008) 112 (11): 4411.

https://doi.org/10.1182/blood.V112.11.4411.4411

Published: 2008

Journal Articles

Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) Combined with Haploidentical Lymphocytes Infusion Increases the Long Term Survival of Adult Acute Myeloid Leukemia with Standard Risk.

Bingyi Wu, MD, Guo Kunyuan, MD, Haiyan Hu, MD, Yuliang Yang, MD, Lan Deng, MD, Jing Wu, MD

Blood (2007) 110 (11): 2879.

https://doi.org/10.1182/blood.V110.11.2879.2879

Published: 2007

Journal Articles

The Long Term Survival of the Patients with Refractory Leukemia Treated by Related HLA Haploidentical Stem Cells Transplantation.

Bingyi Wu, Guo Kunyuan, Haiyan Hu, Yuliang Yang, Lan Deng

Blood (2006) 108 (11): 5388.

https://doi.org/10.1182/blood.V108.11.5388.5388

Published: 2006

NARROW

Safety and Efficacy of Selinexor Plus Bortezomib, Lenalidomide and Dexamethasone (XVRd) in High Risk Newly Diagnosed Multiple Myeloma: A Multi-Center, Single-Arm, Phase Ib/II Trial

Efficiency and Safety of Pegylated Filgrastim Combined with Plerixafor in Multiple Myeloma Autologous Hematopoietic Stem Cells Mobilization

Safety and Efficacy of Luspatercept in Low-Risk Myelodysplastic Neoplasms with Anaemia

Mitoxantrone Hydrochloride Liposome Combined with Cytarabine As Induction Therapy for Patients with Newly Diagnosed Secondary Acute Myeloid Leukemia

ABC Regimen (Azacitidine, Venetoclax and Chidamide) Is Comparable to the “3+7” Regimen in Newly Diagnosed AML: A Real-World Experience from South China

A Preliminary Analysis of Chidamide Combined with R-GemOx (rituximab, gemcitabine and oxaliplatin) As Salvage Treatment for Transplant-Ineligible Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Study

Higher-Dose Donor Derived Ex Vivo Expanded Natural Killer Cell Infusion Prior to Haploidentical Stem Cell Transplantation on Acute Myeloid Leukemia: Efficacy and Safety

Chidamide Plus R-GemOx(rituximab, gemcitabine and oxaliplatin) Regimen As Salvage Treatment for Transplant-Ineligible Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Preliminary Analysis of a Multicenter, Single Arm, Phase II Study

Real-World Effectiveness and Safety of Eltrombopag in Patients with Aplastic Anemia: A Chinese Nationwide Survey

Eltrombopag Combined with G-CSF and Cyclosporine Could Effect for Severe Acquired Aplastic Anemia

Superior Salvage Treatment with Regimen Containing Sorafenib for Relapse of Acute Myeloid Leukemia with FLT3-ITD after Allo-HSCT

The Effect of Sorafenib Therapy on the Outcome of Acute Myeloid Leukemia with FLT3-ITD Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

More Intensity Immuno-Suppression In Conditioning Regimen may Favor Donor Stem Cell Sustained Engraftment In Allogeneic Stem Cell Transplantation For Acquired Severe Aplastic Anemia Patients

Long Term Survival in Refractory Leukemia Patient Treated with Related HLA Haploidentical Stem Cell Transplantation

Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) Combined with Haploidentical Lymphocytes Infusion Increases the Long Term Survival of Adult Acute Myeloid Leukemia with Standard Risk.

The Long Term Survival of the Patients with Refractory Leukemia Treated by Related HLA Haploidentical Stem Cells Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only